Related Experiment Video

Updated: Aug 6, 2026

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl

Alison R Moliterno1, Donna M Williams, Ophelia Rogers

  • 1Johns Hopkins University School of Medicine, Ross Research 1025, 720 Rutland Ave, Baltimore, MD 21205, USA. amoliter@jhmi.edu

Blood
|August 17, 2006
PubMed

Insights

The JAK2 V617F mutation impacts myeloproliferative disorders (MPDs). Aberrant Mpl expression is a common factor in both JAK2 V617F-positive and negative MPDs, suggesting multiple molecular abnormalities.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Activating JAK2 mutations, specifically JAK2 V617F, are implicated in myeloproliferative disorders (MPDs) including polycythemia vera (PV), idiopathic myelofibrosis (IMF), and essential thrombocytosis (ET).
  • JAK2 functions as a chaperone for Mpl, crucial for its cell-surface expression.

Purpose of the Study:

  • To investigate the relationship between JAK2 V617F allele percentage and platelet Mpl expression in MPD patients.
  • To determine the role of aberrant Mpl expression in the pathogenesis of both JAK2 V617F-positive and negative MPDs.

Main Methods:

  • Analysis of neutrophil JAK2 V617F allele percentage.
  • Assessment of platelet Mpl expression levels.
  • Correlation of molecular findings with clinical MPD phenotypes.

Main Results:

  • A reciprocal relationship was observed between neutrophil JAK2 V617F allele percentage and platelet Mpl expression in JAK2 V617F-positive MPDs.
  • Severely impaired platelet Mpl expression was noted in JAK2 V617F-negative MPD patients.
  • The degree of impaired platelet Mpl expression correlated with the MPD phenotype, irrespective of JAK2 V617F status.

Conclusions:

  • Multiple molecular abnormalities contribute to MPD pathogenesis.
  • Aberrant Mpl expression represents a potential common pathway for aberrant signaling in both JAK2 V617F-positive and negative MPDs.

More Related Videos

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...